[1] |
ZHENG Yunxi, YI Xiaofang, XU Congjian.
Progress in the application of non-peptide gonadotropin-releasing hormone antagonist in the treatment of uterine fibroid
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 482-487.
|
[2] |
QIN Xian, WANG Qian, HOU Jia, XU Dongmei.
Stains: recent research progress for endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 488-494.
|
[3] |
HUANG Chunzhi, LIU Qinglan, SU Ran, SUN Nan.
Drug treatment options and research progress of adolescent endometriosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 535-542.
|
[4] |
LI Zhanbo, DU Kaifeng, JIANG Zhilong, GAO Jiameng, CHEN Mengjie, MA Yuan, CHEN Zhihong.
Analysis of the effect of fudosteine on induced sputum components in patients with stable neutrophil-dominated COPD
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 362-369.
|
[5] |
BAI Haodong, SHA Bingxian, Ambedkar Kumar Yadav, XU Xianghuai, YU Li .
Targeted biotherapy for chronic obstructive pulmonary disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 377-382.
|
[6] |
WANG Xiaochuan, WANG Hanchao, YAO Yu, LI Li, HE Gaoyan, LI Bo, ZHU Tao.
Clinical features, risk factors and treatment of type 2 diabetes mellitus in patients with acute exacerbation of chronic obstructive pulmonary disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 392-400.
|
[7] |
LIU Yuru, WU Wenwen, WANG Gang.
Navafenterol, a new drug for the treatment of chronic obstructive airway disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 401-405.
|
[8] |
ZHAO Tingting, LI Junfeng, ZHANG Liting.
Progress in the potential therapeutic mechanism of mesenchymal stem cell-derived exosomes for liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 475-480.
|
[9] |
WU Xingdong, YUE Hongmei, ZHU Haobin, LIU Miaomiao, LI Yating, XU Jinhui.
Research progress of pharmacologic therapy in obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(2): 215-229.
|
[10] |
ZHAO Quanming, YANG Mandou, HU Yibo, SU Youtong, PU Li, ZHANG Yu, LI Wenliang.
Research progress on drug treatment and drug resistance mechanism of gastrointestinal stromal tumors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 82-89.
|
[11] |
YU Miaoying, WANG Yanhui, YAN Shi.
Research progress on molecular mechanism of traditional chinese medicine active ingredients interfering bone marrow mesenchymal stem cells senescence
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 99-106.
|
[12] |
XU Jinhui, YUE Hongmei, LI Yating, LIU Miaomiao, WU Xingdong, ZHU Haobin.
Advances in the study of mesenchymal stem cells in obstructive sleep apnea hypoventilation syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 114-120.
|
[13] |
HE Lihua, ZHU Xiuzhi, JIANG Yizhou.
Research progress on immunotherapy for triple-negative breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 842-853.
|
[14] |
FU Xiaoyu, KONG Deguang, LI Juanjuan.
Treatment progress of triple positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
|
[15] |
WANG Chaoyi, SONG Qiang, XIONG Xin, WANG Mengyuan.
Research progress on diagnosis and treatment of granulomatous lobular mastitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 910-917.
|